InvestorsHub Logo
Followers 90
Posts 17311
Boards Moderated 0
Alias Born 09/06/2006

Re: skitahoe post# 829

Saturday, 01/28/2023 12:57:50 PM

Saturday, January 28, 2023 12:57:50 PM

Post# of 1106
IMGN has always been a fairly straight shooter on estimations, so I agree that the next few weeks are fairly likely. They did not say Q1 or H1.

I agree that Mirasol is very likely a success. Based mainly on the fact that we know the FDA looked at the Mirasol RR data prior to approving. OS may not yet be mature, so might not have that yet.

As far as other jurisdictions, the only other one of serious value is Japan. And they tend to be picky about having trials in Japan, so that will be aways. Australia , S. Korea, Taiwan etc do not move the needle on biotech valuation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News